Difadol 0.1% 1 mg/ml, eye drops, solution
Diclofenac sodium
Difadol 0.1% contains diclofenac sodium, which is a derivative of aminophenylacetic acid, belongs to the group of non-steroidal anti-inflammatory drugs, and also has analgesic properties.
Difadol 0.1% is used:
Before starting treatment with Difadol 0.1%, the patient should discuss it with their doctor.
The patient should inform their doctor or pharmacist about all medicines they are currently taking or have recently taken, as well as any medicines they plan to take.
No interactions with eye drops containing diclofenac have been reported.
Difadol 0.1% can be safely used in combination with antibiotics, steroids, and beta-adrenergic receptor blockers.
If the patient is using another eye medicine, they should wait at least 5 minutes between instillations.
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor or pharmacist before using this medicine.
Pregnancy
The medicine should not be used during the last three months of pregnancy, unless the doctor decides it is absolutely necessary.
Breastfeeding
Diclofenac passes into breast milk in such small amounts that it is unlikely to cause side effects in the breastfed child.
Basically, the medicine does not affect the ability to drive or operate machines.
However, after instillation of the medicine, transient vision disturbances may occur. Patients with vision disturbances should not drive or operate machines.
The medicine contains 0.05 mg of benzalkonium chloride per milliliter.
Benzalkonium chloride may be absorbed by soft contact lenses and change their color. The patient should remove their contact lenses before instillation and wait at least 15 minutes before putting them back on.
Benzalkonium chloride may also cause eye irritation, especially in patients with dry eye syndrome or corneal disorders (the transparent layer at the front of the eye). If the patient experiences any abnormal sensations in the eye, stinging, or eye pain after using the medicine, they should contact their doctor.
This medicine should always be used as directed by the doctor or pharmacist. In case of doubts, the patient should consult their doctor or pharmacist.
Eye surgery and its complications
Before surgery: 5 times 1 drop every 3 hours.
After surgery: 3 times 1 drop per day after surgery, and for the next few days 1 drop 3 to 5 times a day, as long as necessary.
Treatment of pain and photophobia symptoms
1 drop every 4 to 6 hours.
If the pain is a result of surgery, the patient should use 1 to 2 drops 1 hour before surgery, 1 to 2 drops 15 minutes after surgery, and 1 drop every 4 to 6 hours for 3 days after surgery.
No dose adjustment is necessary.
No studies have been conducted on the efficacy and safety of the medicine in children.
Note: If the patient is using another eye medicine, they should wait at least 5 minutes between instillations. Eye ointments should be used last.
The medicine is intended for external use only - locally into the conjunctival sac.
Do not touch the tip of the dropper, as this may contaminate the contents of the bottle.
Overdose after administration into the conjunctival sac, as well as after accidental oral ingestion, is unlikely due to the small amount of active substance.
In case of instillation of too much medicine, excess can be removed by rinsing the eye with saline or cooled boiled water.
Do not use a double dose to make up for a missed dose.
In case of any further doubts about using this medicine, consult a doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
The most common side effect is a transient burning sensation of mild to moderate severity.
Rarely, itching, eye redness, and blurred vision have been observed, which occurred immediately after instillation of the medicine.
After long-term use of the medicine, cases of punctate keratitis and corneal epithelium damage have been reported.
In patients treated with corticosteroid anti-inflammatory drugs, with infection or rheumatoid arthritis, there is a risk of corneal ulceration or thinning, which in rare cases may be increased by diclofenac.
Rarely, shortness of breath and exacerbation of asthma symptoms have been reported.
If side effects occur, including any side effects not listed in this leaflet, the patient should inform their doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181C
02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
e-mail: ndl@urpl.gov.pl
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help gather more information on the safety of the medicine.
Store in a temperature below 25°C.
Keep the bottle tightly closed, in the outer packaging to protect from light.
Keep the medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the carton and bottle. The expiry date refers to the last day of the month.
The inscription on the packaging after the abbreviation "EXP" means the expiry date, and after the abbreviation "Lot" means the batch number.
After opening the bottle, do not use the medicine for more than 4 weeks.
Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
Difadol 0.1% is a sterile eye drop solution, in the form of a colorless or pale yellow, clear liquid.
The medicine is available in polyethylene bottles containing 5 ml of solution, packaged in a cardboard box.
PHARMACEUTICAL WORKS POLPHARMA S.A.
Pelplińska 19, 83-200 Starogard Gdański
phone: +48 22 364 61 01
Warsaw Pharmaceutical Works Polfa S.A.
Karolkowa 22/24, 01-207 Warsaw
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.